3.60Open3.60Pre Close0 Volume2 Open Interest83.00Strike Price0.00Turnover44.60%IV-2.86%PremiumDec 20, 2024Expiry Date5.81Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9286Delta0.0385Gamma13.08Leverage Ratio-0.0467Theta-0.0063Rho-12.15Eff Leverage0.0115Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet